Accenture CEO Julie Sweet has been diagnosed with breast cancer at an early stage and treatment will probably take 12-16 weeks according to the Money Control check report. However, the CEO will continue to take care of the daily operation of IT services and consulting firm during treatment.
“Recently I was diagnosed with breast cancer.” The good news is that the prognosis from my doctor is excellent; Cancer was caught soon and my condition is curable, ”said Sweet allegedly told Accenture employees in the internal e -mail.
The scanning confirmed that there was no evidence of cancer elsewhere in the body, added her letter. After the next week's operation, Sweet's further treatment would include radiation.
Accenture is one of the largest employers of IT services with approximately 3 lakh employees in India.
“As mentioned in the note that Julie sent to our people, her forecast is excellent, cancer was caught soon and her condition is curable. It will work significantly as normal and will continue to lead the daily operation of the company “MoneyControl said he was quoted by Accenture spokesman.
However, during the period it will limit travel. The Accenture Council has been informed and fully supports development.
“We have an incredible Global Management Committee, supported by our amazing teams around the world. I am convinced that we will continue to do what we do best- bring 360 ° for our clients, people, shareholders, partners and communities, ”Sweet's mail read further.
Sweet was appointed CEO of Accenture in September 2019. Previously, she worked as the CEO of Accenture, North America, the largest geographical market of the company.
It also operates in the World Board of the Economic Forum.
